Brothers Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.40 M
- Revenue Growth %
- Net Worth 2.92%
- Total Assets -1.93%
About Brothers Pharma
Brothers Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 July 1986 and has a history of 38 years and seven months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.40 M.
Bela Khurana and Rajesh Khurana serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ1986PTC003682
- Company No.
003682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Brothers Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bela Khurana  | Director | 04-Jul-1986 | Current |
| Rajesh Khurana | Director | 03-Dec-2014 | Current |
Financial Performance of Brothers Pharma.
Brothers Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 2.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Brothers Pharma?
In 2021, Brothers Pharma had a promoter holding of 72.53% and a public holding of 27.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.40 M
₹0
Charges Breakdown by Lending Institutions
- The Bank Of Rajasthan Ltd. : 0.65 Cr
- The Rajasthan Financial Ltd. : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 1994 | The Bank Of Rajasthan Ltd. | ₹6.50 M | Open |
| 31 Jan 1994 | The Rajasthan Financial Ltd. | ₹1.10 M | Open |
| 01 Aug 1988 | The Rajasthan Financial Ltd. | ₹1.80 M | Open |
How Many Employees Work at Brothers Pharma?
Unlock and access historical data on people associated with Brothers Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brothers Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brothers Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
